Utah Medical Products Inc... (UTMD)
NASDAQ: UTMD
· Real-Time Price · USD
56.10
-0.77 (-1.35%)
At close: Aug 15, 2025, 12:21 PM
Utah Medical Products Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 9.95M | 9.71M | 9.16M | 10.01M | 10.4M | 11.34M | 12.33M | 12.51M | 12.87M | 12.52M | 13.57M | 12.96M | 13.43M | 12.32M | 12.91M | 12.57M | 12.6M | 10.96M |
Cost of Revenue | 4.9M | 4.17M | 3.83M | 4.2M | 4.66M | 4.57M | 6.1M | 5.15M | 5.13M | 4.68M | 5.25M | 4.77M | 5.28M | 4.79M | 4.8M | 4.5M | 4.82M | 4.02M |
Gross Profit | 5.06M | 5.54M | 5.32M | 5.8M | 5.74M | 6.77M | 6.23M | 7.36M | 7.74M | 7.84M | 8.33M | 8.19M | 8.15M | 7.53M | 8.11M | 8.07M | 7.79M | 6.95M |
Operating Income | 3.2M | 3.15M | 2.93M | 3.34M | 3.44M | 3.88M | 3.94M | 3.97M | 4.42M | 4.44M | 5.07M | 5.14M | 5.06M | 4.52M | 5.13M | 5.1M | 4.76M | 3.89M |
Interest Income | n/a | n/a | n/a | n/a | n/a | 915K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 3.83M | 3.86M | 3.61M | 4.18M | 4.21M | 4.8M | 5.02M | 4.78M | 5.17M | 5.12M | 5.59M | 5.34M | 5.2M | 4.53M | 5.18M | 5.16M | 4.83M | 3.9M |
Net Income | 3.05M | 3.04M | 2.9M | 3.56M | 3.45M | 3.96M | 4.29M | 3.94M | 4.2M | 4.21M | 4.55M | 4.28M | 4.1M | 3.53M | 4.13M | 4.21M | 3.43M | 3.02M |
Selling & General & Admin | 1.73M | 2.23M | 1.39M | 2.29M | 2.56M | 1.36M | 3.01M | 3.25M | 3.18M | 1.26M | 3.13M | 2.93M | 2.96M | 2.89M | 2.84M | 2.85M | 2.89M | 2.93M |
Research & Development | 135K | 155K | 121K | 172K | 255K | 266K | 146K | 138K | 133K | 144K | 123K | 112K | 135K | 123K | 141K | 127K | 128K | 130K |
Other Expenses | n/a | n/a | 337K | n/a | n/a | 751K | n/a | n/a | -3.31M | 2M | n/a | n/a | n/a | 8K | n/a | n/a | n/a | 10K |
Operating Expenses | 1.86M | 2.39M | 2.39M | 2.46M | 2.81M | 2.88M | 3.15M | -3.39M | -3.31M | 3.4M | 3.26M | 3.04M | 3.09M | 3.01M | 2.98M | 2.98M | 3.02M | 3.06M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 1.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | 505K | n/a | 546K | 412K | 1.69M | 417K | n/a | 387K | 1.51M | n/a | n/a | n/a | 1.41M | n/a | n/a | n/a |
Cost & Expenses | 6.76M | -6.56M | 6.23M | 6.66M | 6.96M | 7.46M | 8.39M | 1.76M | 8.44M | 8.08M | 8.5M | 7.81M | 8.37M | 7.8M | 7.78M | 7.47M | 7.84M | 7.08M |
Income Tax Expense | 787K | 818K | 712K | 616K | 758K | 842K | 730K | 846K | 972K | 905K | 1.04M | 1.06M | 1.1M | 996K | 1.05M | 951K | 1.4M | 874K |
Shares Outstanding (Basic) | 3.31M | 3.31M | 3.39M | 3.48M | 3.62M | 3.62M | 3.63M | 3.63M | 3.63M | 3.63M | 3.63M | 3.63M | 3.64M | 3.65M | 3.65M | 3.65M | 3.65M | 3.64M |
Shares Outstanding (Diluted) | 3.25M | 3.31M | 3.39M | 3.48M | 3.53M | 3.62M | 3.63M | 3.64M | 3.64M | 3.64M | 3.63M | 3.63M | 3.65M | 3.67M | 3.67M | 3.66M | 3.65M | 3.65M |
EPS (Basic) | 0.92 | 0.92 | 0.86 | 1.02 | 0.95 | 1.09 | 1.18 | 1.08 | 1.16 | 1.16 | 1.26 | 1.18 | 1.13 | 0.97 | 1.13 | 1.15 | 0.94 | 0.83 |
EPS (Diluted) | 0.94 | 0.92 | 0.86 | 1.02 | 0.98 | 1.09 | 1.18 | 1.08 | 1.15 | 1.16 | 1.25 | 1.18 | 1.12 | 0.96 | 1.13 | 1.15 | 0.94 | 0.83 |
EBITDA | 4.58M | 3.15M | 3.98M | 4.08M | 4.13M | 5.32M | 4.98M | 5.75M | 6.2M | 6.61M | 6.82M | 6.89M | 6.83M | 6.33M | 6.9M | 6.93M | 6.61M | 5.72M |
EBIT | 3.84M | 3.86M | 3.26M | 3.34M | 3.44M | 4.63M | 3.94M | 3.97M | 4.42M | 4.85M | 5.07M | 5.14M | 5.06M | 4.52M | 5.13M | 5.1M | 4.76M | 3.89M |
Depreciation & Amortization | 745K | -705K | 730K | 728K | 693K | 683K | 1.04M | 1.78M | 1.78M | 1.76M | 1.75M | 1.75M | 1.78M | 1.81M | 1.77M | 1.83M | 1.84M | 1.84M |